OptimizeRx Corp — Director's Dealing 2022

Apr 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2022-03-30

Reporting Person: Lang James Paul (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-30	Restricted Stock Units	$	A	657	Acquired		Common Stock (657)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

F2: The restricted stock units vest on March 30, 2023.